Marvion Inc. Announces Annual Financial Results for 2024 with 134% Gain in Year-to-Year Revenue
HONG KONG, April 28, 2025 /PRNewswire/ -- Marvion Inc. (OTC: MNVC) filed and reported the financial results with the period ended 31 December, 2025. For annual fiscal period ended 31 December, 2024, the company achieved a revenue of $1,544,108 with...
Bright Scholar Announces Unaudited Financial Results for the Second Quarter of Fiscal Year 2025
Net income from continuing operations increased 223.6% YoY to GBP3.2 million Management to hold a conference call today at 7 :00 a.m. Eastern Time CAMBRIDGE, England and FOSHAN, China, April 28, 2025 /PRNewswire/ -- Bright Scholar Education Holdings...
Comac Medical Announces New Leadership Appointments and International Expansion
Leadership transition and strategic growth initiatives mark the next phase of Comac Medical's development under EdgeCap Partners. SOFIA, Bulgaria, April 28, 2025 /PRNewswire/ -- Comac Medical, a leading full-service Contract Research Organization...
SMU wins prestigious THE Awards Asia 2025 – Teaching & Learning Strategy of the Year
SINGAPORE, April 28, 2025 /PRNewswire/ -- Singapore Management University (SMU) is proud to announce that it has been named Winner in the 'Teaching and Learning Strategy of the Year' category at the prestigious Times Higher Education (THE) Awards...
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
SHANGHAI, April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, announced promising interim clinical data from an...
TIER IV accelerates the deployment of autonomous trucks following completion of Japanese government initiative
TOKYO, April 28, 2025 /PRNewswire/ -- TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, is thrilled to announce the successful completion of an initiative aimed at developing autonomous trucks to...
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs
SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Everest Medicines Announces the "B" Marker Removal from Company's Stock Code, Effective May 2, 2025
SHANGHAI, April 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...
ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups
Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ -- ONO PHARMA USA today announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San...
MDJM LTD Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
LETHAM, Scotland, April 26, 2025 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the Company received a staff determination letter (the "Letter"),...